Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global endometriosis treatment market was estimated to be worth USD 1.55 billion in 2023. The market is expected to grow at a CAGR of 7.7% during the forecast period of 2024-2032 to attain a market value of USD 3.02 billion by 2032. The growth of the market is driven by the rising research and development activities.
Endometriosis is a medical condition in which the tissue lining the uterus grows outside the uterus, causing pain and discomfort. The condition is often associated with infertility, and it affects millions of women worldwide. The global endometriosis treatment market is highly competitive, with key players focusing on research and development activities to develop innovative products and strengthen their market position.
Endometriosis Treatment Drugs Market Size
Endometriosis Treatment Drugs Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The endometriosis market attained a value of nearly USD 1.55 billion in 2023.
The market is projected to grow at a CAGR of 7.7% during the forecast period of 2024-2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach USD 3.02 billion by 2032.
The growth of the market is driven by factors like rising cases of endometriosis due to the rising issues in women of reproductive age and the rising awareness about the disease.
The rapid advancements and developments in the market acts as a key trend for the market.
The indications of the disease include superficial peritoneal lesion, endometrioma, and deeply infiltrating endometriosis, among others.
The diagnostic methods include ultrasound, pelvic examination, laparoscopy, and magnetic resonance imaging, among others.
The treatment methods include hormonal therapy and pain management, among others.
The drugs include oral contraceptives, progestins, NSAIDs, and GnRH analogues, among others.
The distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest share of the market.
The key players in the market include Abbott, AbbVie Inc., Bayer AG, Pfizer Inc., Ipsen Pharma, Evotec SE, Myovant Sciences GmbH, Philogen S.p.A., Astellas Pharma Inc., and Orphagen Pharmaceuticals, among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124